These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37899490)

  • 21. Impact of Hospital Volume and the Experience of Endoscopist on Adverse Events Related to Endoscopic Retrograde Cholangiopancreatography: A Prospective Observational Study.
    Lee HJ; Cho CM; Heo J; Jung MK; Kim TN; Kim KH; Kim H; Cho KB; Kim HG; Han J; Lee DW; Lee YS
    Gut Liver; 2020 Mar; 14(2):257-264. PubMed ID: 31060119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ERCP-Related Adverse Events in Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis.
    Natt N; Michael F; Michael H; Dubois S; Al Mazrou'i A
    Can J Gastroenterol Hepatol; 2022; 2022():2372257. PubMed ID: 35910039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complications of ERCP.
    Guda NM; Reddy DN; Kumar A
    Indian J Gastroenterol; 2014 Jan; 33(1):1-9. PubMed ID: 24043399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatography.
    Brand M; Bizos D; O'Farrell P
    Cochrane Database Syst Rev; 2010 Oct; (10):CD007345. PubMed ID: 20927758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of center and endoscopist ERCP volume on ERCP outcomes: a systematic review and meta-analysis.
    Teles de Campos S; Papaefthymiou A; Florou T; Facciorusso A; Arvanitakis M; Devière J; Gkolfakis P
    Gastrointest Endosc; 2023 Sep; 98(3):306-315.e14. PubMed ID: 37201726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoscopic retrograde cholangiopancreatography-related adverse events in patients with type 1 autoimmune pancreatitis.
    Naitoh I; Nakazawa T; Okumura F; Takada H; Hirano A; Hayashi K; Miyabe K; Shimizu S; Kondo H; Nishi Y; Yoshida M; Umemura S; Hori Y; Kato A; Yamashita H; Sano H; Ohara H; Joh T
    Pancreatology; 2016; 16(1):78-82. PubMed ID: 26626204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy.
    NIH Consens State Sci Statements; 2002 Jan 14-16; 19(1):1-26. PubMed ID: 14768653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Bai Y; Xu C; Yang X; Gao J; Zou DW; Li ZS
    Endoscopy; 2009 Aug; 41(8):690-5. PubMed ID: 19670137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients.
    Sawas T; Bazerbachi F; Haffar S; Cho WK; Levy MJ; Martin JA; Petersen BT; Topazian MD; Chandrasekhara V; Abu Dayyeh BK
    World J Gastroenterol; 2018 Nov; 24(41):4691-4697. PubMed ID: 30416316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of endoscopic nasobiliary drainage for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and cholangitis after repeated clearance of common bile duct stones: experience from a Chinese center.
    Yang J; Peng JY; Pang EJ; Chen W
    Dig Endosc; 2013 Jul; 25(4):453-8. PubMed ID: 23363031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tacrolimus and Indomethacin Are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation.
    Thiruvengadam NR; Forde KA; Chandrasekhara V; Ahmad NA; Ginsberg GG; Khungar V; Kochman ML
    Clin Gastroenterol Hepatol; 2020 May; 18(5):1224-1232.e1. PubMed ID: 31622734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diclofenac does not reduce the risk of acute pancreatitis in patients with primary sclerosing cholangitis after endoscopic retrograde cholangiography.
    Koskensalo V; Tenca A; Udd M; Lindström O; Rainio M; Jokelainen K; Kylänpää L; Färkkilä M
    United European Gastroenterol J; 2020 May; 8(4):462-471. PubMed ID: 32213036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis.
    Bangarulingam SY; Gossard AA; Petersen BT; Ott BJ; Lindor KD
    Am J Gastroenterol; 2009 Apr; 104(4):855-60. PubMed ID: 19259076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoscopic retrograde cholangiopancreatography (ERCP)-related adverse events: post-ERCP pancreatitis.
    Rustagi T; Jamidar PA
    Gastrointest Endosc Clin N Am; 2015 Jan; 25(1):107-21. PubMed ID: 25442962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis.
    Budzyńska A; Marek T; Nowak A; Kaczor R; Nowakowska-Dulawa E
    Endoscopy; 2001 Sep; 33(9):766-72. PubMed ID: 11558030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
    Kawaguchi Y; Ogawa M; Omata F; Ito H; Shimosegawa T; Mine T
    World J Gastroenterol; 2012 Apr; 18(14):1635-41. PubMed ID: 22529693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial.
    Sperna Weiland CJ; Smeets XJNM; Kievit W; Verdonk RC; Poen AC; Bhalla A; Venneman NG; Witteman BJM; da Costa DW; van Eijck BC; Schwartz MP; Römkens TEH; Vrolijk JM; Hadithi M; Voorburg AMCJ; Baak LC; Thijs WJ; van Wanrooij RL; Tan ACITL; Seerden TCJ; Keulemans YCA; de Wijkerslooth TR; van de Vrie W; van der Schaar P; van Dijk SM; Hallensleben NDL; Sperna Weiland RL; Timmerhuis HC; Umans DS; van Hooft JE; van Goor H; van Santvoort HC; Besselink MG; Bruno MJ; Fockens P; Drenth JPH; van Geenen EJM;
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):350-358. PubMed ID: 33740415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-ERCP pancreatitis.
    Arata S; Takada T; Hirata K; Yoshida M; Mayumi T; Hirota M; Yokoe M; Hirota M; Kiriyama S; Sekimoto M; Amano H; Wada K; Kimura Y; Gabata T; Takeda K; Kataoka K; Ito T; Tanaka M
    J Hepatobiliary Pancreat Sci; 2010 Jan; 17(1):70-8. PubMed ID: 20012323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
    World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoscopic Retrograde Cholangiopancreatography-Related Complications and Their Management Strategies: A "Scoping" Literature Review.
    Johnson KD; Perisetti A; Tharian B; Thandassery R; Jamidar P; Goyal H; Inamdar S
    Dig Dis Sci; 2020 Feb; 65(2):361-375. PubMed ID: 31792671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.